Financials

  • Market Capitalization 279.8586 M
  • Employee 86
  • Founded 2014
  • CEO N/A
  • Website www.sab.bio
  • Headquarter Delaware, United States
  • FIGI BBG00YHY0G24
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.04
Price to sales ratio

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
6996
RCKTW
Rocket Pharmaceuticals, Inc. - Warrant
0.0029 USD-3.33%-3.33%-42.00%-92.54%404.02 M USD
7114
OABIW
OmniAb, Inc. - Warrant
0.0809 USD0.00%0.00%+32.62%-65.19%305.89 M USD
7165
SRZNW
Surrozen, Inc. - Warrant
0.0098 USD0.00%+2.08%-48.96%-47.03%263.90 M USD
7273
HUMAW
Humacyte, Inc. - Warrant
0.0091 USD+19.74%-9.00%-61.44%-98.11%157.63 M USD

Frequently asked questions about SAB Biotherapeutics, Inc. - Warrant

What is the SAB Biotherapeutics, Inc. - Warrant stock price today?

The current price of SAB Biotherapeutics, Inc. - Warrant (SABSW) is 0.0153. Over the past 24 hours, the stock has changed by +22.40%. Follow the SABSW chart for real-time price dynamics.

What is the stock ticker of SAB Biotherapeutics, Inc. - Warrant?

SAB Biotherapeutics, Inc. - Warrant trades under the ticker SABSW. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is SAB Biotherapeutics, Inc. - Warrant stock going up?

SABSW has changed by -38.31% over the last week, +19.53% over the last month, and -69.88% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was SAB Biotherapeutics, Inc. - Warrant net income for the last quarter?

SAB Biotherapeutics, Inc. - Warrant reported net income of -18.87 M for the last quarter. The previous quarter showed -16.86 M, which means net income changed by -11.91%.

How many employees does SAB Biotherapeutics, Inc. - Warrant have?

As of the latest available data, SAB Biotherapeutics, Inc. - Warrant has 86 employees. Workforce size can provide additional context about the company's scale and operations.

What is SAB Biotherapeutics, Inc. - Warrant EBITDA?

SAB Biotherapeutics, Inc. - Warrant EBITDA is -19.21 M, and its EBITDA margin is -37.06 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy SAB Biotherapeutics, Inc. - Warrant stock?

You can buy SAB Biotherapeutics, Inc. - Warrant (SABSW) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in SAB Biotherapeutics, Inc. - Warrant stock?

Investing in SAB Biotherapeutics, Inc. - Warrant requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SABSW chart and related analysis on metatrader.com as part of your research.